Gevo Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Gevo hat ein Gesamteigenkapital von $504.7M und eine Gesamtverschuldung von $67.0M, was einen Verschuldungsgrad von 13.3% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $603.8M bzw. $99.1M.

Wichtige Informationen

13.3%

Verhältnis von Schulden zu Eigenkapital

US$66.96m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$223.23m
Eigenkapital	US$504.72m
Gesamtverbindlichkeiten	US$99.07m
Gesamtvermögen	US$603.79m

Jüngste Berichte zur Finanzlage

Recent updates

Gevo Makes Funding Progress But Competitive Risks Loom

Oct 23

Gevo: Expensive Ethanol Plant Acquisition May Not Meet Expectations -- Sell

Sep 16

Gevo, Inc. (NASDAQ:GEVO) Analysts Are Reducing Their Forecasts For This Year

May 07

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

Nov 10

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

May 29

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Feb 22

Is Gevo (NASDAQ:GEVO) Weighed On By Its Debt Load?

Oct 04

Gevo Inc. Is Strongly On Track To Become A Leader In The SAF Market

Sep 15

Gevo Has Finally Reached Levels That Make The Shares Attractive

Jun 21

Earth First Investments 4: 2022 Is Key Year For Gevo's Biofuel Commercialization

Apr 05

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Mar 09

Is Gevo Stock Undervalued Or Overvalued? Focus On The Execution First

Dec 16

Is Gevo Stock A Buy, Sell, Or Hold During The Dip?

Dec 07

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Nov 05

Best Of Seeking Alpha Blog Posts Newsletter: Gevo Signs Deals For Renewables With Big Oil

Sep 15

Gevo Will Put You At A Crossroad

Jul 06

Gevo set to join Russell 3000 Index

Jun 08

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: GEVODie kurzfristigen Aktiva des Unternehmens ($236.6M) übersteigen seine kurzfristigen Passiva ($28.7M).

Langfristige Verbindlichkeiten: GEVODie kurzfristigen Vermögenswerte des Unternehmens ($236.6M) übersteigen seine langfristigen Verbindlichkeiten ($70.4M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: GEVO über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: GEVO Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 17.7% auf 13.3% zurückgegangen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: GEVO auf der Grundlage seines derzeitigen freier Cashflows über eine ausreichende Liquiditätsreserve für mehr als ein Jahr verfügt.

Vorhersage Cash Runway: GEVO hat weniger als ein Jahr Liquiditätsreserven, wenn der freie Cashflow weiterhin mit den historischen Raten von 29.8% pro Jahr abnimmt

Gevo Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Nasdaq Grants Gevo an Additional 180 Calendar Days, or Until February 24, 2025, to Regain Compliance with the Minimum Bid Price Requirement

Gevo Receives Notice from the Nasdaq Regarding Not in Compliance with Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Is Gevo (NASDAQ:GEVO) Weighed On By Its Debt Load?

Recent updates

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Chief Marketing notifies of intention to sell stock

Gevo, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Gevo Makes Funding Progress But Competitive Risks Loom

Gevo: Expensive Ethanol Plant Acquisition May Not Meet Expectations -- Sell

New major risk - Share price stability

Nasdaq Grants Gevo an Additional 180 Calendar Days, or Until February 24, 2025, to Regain Compliance with the Minimum Bid Price Requirement

CEO & Director notifies of intention to sell stock

Consensus revenue estimates increase by 18%

New major risk - Revenue and earnings growth

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 41% to US$7.30

CEO & Director notifies of intention to sell stock

Gevo, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Price target increased by 16% to US$5.18

New major risk - Financial position

Consensus revenue estimates fall by 11%

Gevo, Inc. (NASDAQ:GEVO) Analysts Are Reducing Their Forecasts For This Year

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Gevo, Inc. to Report Q1, 2024 Results on May 02, 2024

Gevo, Inc., Annual General Meeting, May 21, 2024

Full year 2023 earnings: EPS misses analyst expectations

No longer forecast to breakeven

Gevo Receives Notice from the Nasdaq Regarding Not in Compliance with Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement

Gevo, Inc. Hires Damien Perriman as Chief Business Development Officer

Gevo, Inc. to Report Q4, 2023 Results on Mar 07, 2024

Price target increased by 10% to US$4.64

Gevo, Inc. has filed a Follow-on Equity Offering in the amount of $500 million.

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

Gevo, Inc. Appoints Angelo Amorelli as Board of Directors

Gevo, Inc. to Report Q3, 2023 Results on Nov 08, 2023

New minor risk - Share price stability

Gevo, Inc. Announces the Resignation of Timothy J. Cesarek, Chief Commercial Officer, Effective September 22, 2023

CEO & Director notifies of intention to sell stock

New minor risk - Profitability

No longer forecast to breakeven

Price target decreased by 17% to US$4.95

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target increased by 19% to US$7.43

CEO & Director notifies of intention to sell stock

Forecast to breakeven in 2025

Gevo, Inc. Appoints Nancy N. Young as Chief Sustainability Officer

Price target decreased by 8.8% to US$5.93

Is Gevo (NASDAQ:GEVO) Using Too Much Debt?

Independent Director notifies of intention to sell stock

Price target increased by 15% to US$7.90

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Forecast breakeven date moved forward to 2024

Consensus EPS estimates fall by 12%

Consensus EPS estimates fall by 25%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Is Gevo (NASDAQ:GEVO) A Risky Investment?

Consensus revenue estimates decrease by 12%

Gevo, Inc. to Report Q4, 2022 Results on Mar 09, 2023

Less than half of directors are independent

Gevo, Inc. Appoints Carol Battershell to Board of Directors

Forecast to breakeven in 2025

Consensus forecasts updated

Consensus revenue estimates increase by 22%

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Gevo, Inc. Reports Impairment Loss for the Third Quarter Ended September 30, 2022

Gevo, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Is Gevo (NASDAQ:GEVO) Weighed On By Its Debt Load?

Gevo Inc. Is Strongly On Track To Become A Leader In The SAF Market

Price target decreased to US$12.33

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Gevo Has Finally Reached Levels That Make The Shares Attractive